Capricorn


Shareholders take a victorious breath, yet challenges remain

24/01/23 -"After months of campaigning, Capricorn shareholders have managed to bring about the first steps towards a new board. They have also gained a likely negotiating position in the merger with NewMed ..."

Pages
71
Language
English
Published on
24/01/23
You may also be interested by these reports :
01/02/23
Improved FY2023 and FY2024 profit and cash flow estimates gave a bump up to the target price. The post-Russian-impairment ($14.7bn) visibility bodes ...

31/01/23
PGS is enjoying the uptick in global upstream investments with attractive prospects in the medium term. The 44% annual jump in Q4 FY22 revenues and ...

27/01/23
Fugro’s performance on deleveraging in FY2022, the backlog growth and the continuing diversification of revenue streams are the main catalysts for ...

24/01/23
After months of campaigning, Capricorn shareholders have managed to bring about the first steps towards a new board. They have also gained a likely ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO